Search research articles
Contact Us
Filters
Showing results (21-30 of 112) with videos related to
Page
of 12
Sort By:
The New England Journal of Medicine
|
March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney Disease
Martin Schumacher, Christoph Wanner, Jan Beyersmann
Biometrical Journal. Biometrische Zeitschrift
|
December 17, 2024
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression-Free and Overall Survival Endpoints
Alexandra Erdmann, Jan Beyersmann, Kaspar Rufibach
Pharmaceutical Statistics
|
December 11, 2019
Multistate modeling of clinical hold in randomized clinical trials
Alexandra Nießl, Jan Beyersmann, Anja Loos
Statistical Methods in Medical Research
|
December 5, 2022
A connection between survival multistate models and causal inference for external treatment interruptions
Alexandra Erdmann, Anja Loos, Jan Beyersmann
Biometrics
|
June 28, 2022
General independent censoring in event-driven trials with staggered entry
Jasmin Rühl, Jan Beyersmann, Sarah Friedrich
Statistics in Medicine
|
March 10, 2010
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified
Nadine Grambauer, Martin Schumacher, Jan Beyersmann
Lifetime Data Analysis
|
March 8, 2018
The wild bootstrap for multivariate Nelson-Aalen estimators
Tobias Bluhmki, Dennis Dobler, Jan Beyersmann, et al.
Statistics in Medicine
|
January 7, 2009
Simulating competing risks data in survival analysis
Jan Beyersmann, Aurélien Latouche, Anika Buchholz, et al.
Intensive Care Medicine
|
February 3, 2009
Modeling the effect of time-dependent exposure on intensive care unit mortality
Martin Wolkewitz, Jan Beyersmann, Petra Gastmeier, et al.
Infection Control and Hospital Epidemiology
|
February 6, 2009
Nosocomial infection, length of stay, and time-dependent bias
Jan Beyersmann, Thomas Kneib, Martin Schumacher, et al.
Page
of 12
Search research articles
Search
Showing results (21-30 of 112) with videos related to
Sort By:
Page
of 12
The New England Journal of Medicine
|
March 11, 2016
Soluble Urokinase Receptor and Chronic Kidney Disease
Martin Schumacher, Christoph Wanner, Jan Beyersmann
Biometrical Journal. Biometrische Zeitschrift
|
December 17, 2024
Oncology Clinical Trial Design Planning Based on a Multistate Model That Jointly Models Progression-Free and Overall Survival Endpoints
Alexandra Erdmann, Jan Beyersmann, Kaspar Rufibach
Pharmaceutical Statistics
|
December 11, 2019
Multistate modeling of clinical hold in randomized clinical trials
Alexandra Nießl, Jan Beyersmann, Anja Loos
Statistical Methods in Medical Research
|
December 5, 2022
A connection between survival multistate models and causal inference for external treatment interruptions
Alexandra Erdmann, Anja Loos, Jan Beyersmann
Biometrics
|
June 28, 2022
General independent censoring in event-driven trials with staggered entry
Jasmin Rühl, Jan Beyersmann, Sarah Friedrich
Statistics in Medicine
|
March 10, 2010
Proportional subdistribution hazards modeling offers a summary analysis, even if misspecified
Nadine Grambauer, Martin Schumacher, Jan Beyersmann
Lifetime Data Analysis
|
March 8, 2018
The wild bootstrap for multivariate Nelson-Aalen estimators
Tobias Bluhmki, Dennis Dobler, Jan Beyersmann, et al.
Statistics in Medicine
|
January 7, 2009
Simulating competing risks data in survival analysis
Jan Beyersmann, Aurélien Latouche, Anika Buchholz, et al.
Intensive Care Medicine
|
February 3, 2009
Modeling the effect of time-dependent exposure on intensive care unit mortality
Martin Wolkewitz, Jan Beyersmann, Petra Gastmeier, et al.
Infection Control and Hospital Epidemiology
|
February 6, 2009
Nosocomial infection, length of stay, and time-dependent bias
Jan Beyersmann, Thomas Kneib, Martin Schumacher, et al.
Page
of 12